Compare PTCT & CRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | CRC |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.7B |
| IPO Year | 2006 | N/A |
| Metric | PTCT | CRC |
|---|---|---|
| Price | $72.08 | $61.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 7 |
| Target Price | ★ $80.65 | $72.57 |
| AVG Volume (30 Days) | ★ 1.4M | 767.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $12.37 |
| Revenue Next Year | $17.70 | N/A |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $41.13 |
| 52 Week High | $87.50 | $71.98 |
| Indicator | PTCT | CRC |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 42.95 |
| Support Level | $61.59 | $45.51 |
| Resistance Level | $79.67 | $71.21 |
| Average True Range (ATR) | 3.55 | 2.25 |
| MACD | 0.59 | -0.69 |
| Stochastic Oscillator | 49.85 | 25.25 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.